| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.95▲ | 6.95▲ | 6.95▼ | 6.85▲ | 6.82▲ |
| MA10 | 6.95▼ | 6.93▲ | 6.97▼ | 6.81▲ | 6.62▲ |
| MA20 | 6.96▼ | 6.96▼ | 6.92▲ | 6.88▲ | 7.35▼ |
| MA50 | 6.93▲ | 6.85▲ | 6.78▲ | 6.73▲ | 9.37▼ |
| MA100 | 6.97▼ | 6.78▲ | 6.77▲ | 7.80▼ | 7.34▼ |
| MA200 | 6.94▲ | 6.78▲ | 6.72▲ | 10.09▼ | 5.52▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.009▼ | -0.007▼ | 0.015▲ | 0.074▲ |
| RSI | 50.589▲ | 52.317▲ | 55.194▲ | 53.251▲ | 43.982▼ |
| STOCH | 43.254 | 46.794 | 37.847 | 55.872 | 50.216 |
| WILL %R | -57.143 | -61.017 | -54.545 | -24.731▲ | -46.302 |
| CCI | -55.338 | -5.047 | -20.426 | 100.154▲ | 61.943 |
|
Monday, July 07, 2025 02:42 PM
Wave Life Sciences Ltd. shows promise with AATD, DMD, and Huntington's programs. Click for my updated look at WVE stock and why I'm bullish.
|
|
Monday, July 07, 2025 02:10 AM
Wave Life Sciences could offer significant upside if obesity candidate WVE-007 delivers strong human data. Check out the detailed analysis of WVE stock.
|
|
Thursday, July 03, 2025 06:18 AM
Wave Life Sciences Ltd. (NASDAQ:WVE) ranks among the best CRISPR stocks to buy. On June 23, H.C. Wainwright maintained its $22 price target and Buy rating on Wave Life Sciences Ltd. (NASDAQ:WVE). The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/07/25 | 7.07 | 7.13 | 6.835 | 6.95 | 884,900 |
| 07/07/25 | 6.85 | 7.10 | 6.825 | 7.06 | 1,401,542 |
| 03/07/25 | 6.80 | 7.0054 | 6.69 | 6.95 | 652,460 |
| 02/07/25 | 6.55 | 6.86 | 6.48 | 6.75 | 904,004 |
| 01/07/25 | 6.48 | 6.69 | 6.25 | 6.52 | 1,266,100 |
| 30/06/25 | 6.70 | 6.77 | 6.49 | 6.50 | 850,800 |
| 27/06/25 | 7.07 | 7.07 | 6.62 | 6.67 | 2,235,796 |
| 26/06/25 | 6.84 | 7.10 | 6.78 | 7.03 | 774,400 |
| 25/06/25 | 6.84 | 6.98 | 6.67 | 6.85 | 1,042,600 |
| 24/06/25 | 7.05 | 7.18 | 6.80 | 6.83 | 1,163,800 |
|
|
||||
|
|
||||
|
|